Aethlon Medical Statistics

Total Valuation

Aethlon Medical has a market cap or net worth of $2.49 million. The enterprise value is -$2.18 million.

Market Cap	2.49M
Enterprise Value	-2.18M

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025, after market close.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Aethlon Medical has 2.01 million shares outstanding. The number of shares has increased by 396.93% in one year.

Current Share Class	2.01M
Shares Outstanding	2.01M
Shares Change (YoY)	+396.93%
Shares Change (QoQ)	+4.15%
Owned by Insiders (%)	1.39%
Owned by Institutions (%)	4.51%
Float	1.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.49
P/TBV Ratio	0.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.13, with a Debt / Equity ratio of 0.16.

Current Ratio	3.13
Quick Ratio	2.90
Debt / Equity	0.16
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-924.06

Financial Efficiency

Return on equity (ROE) is -245.88% and return on invested capital (ROIC) is -92.25%.

Return on Equity (ROE)	-245.88%
Return on Assets (ROA)	-74.82%
Return on Invested Capital (ROIC)	-92.25%
Return on Capital Employed (ROCE)	-171.08%
Revenue Per Employee	n/a
Profits Per Employee	-$956,292
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.91% in the last 52 weeks. The beta is 1.69, so Aethlon Medical's price volatility has been higher than the market average.

Beta (5Y)	1.69
52-Week Price Change	-62.91%
50-Day Moving Average	2.55
200-Day Moving Average	3.51
Relative Strength Index (RSI)	30.76
Average Volume (20 Days)	291,261

Short Selling Information

The latest short interest is 28,330, so 1.41% of the outstanding shares have been sold short.

Short Interest	28,330
Short Previous Month	94,651
Short % of Shares Out	1.41%
Short % of Float	1.72%
Short Ratio (days to cover)	0.66

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.34M
Pretax Income	-12.21M
Net Income	-13.39M
EBITDA	-9.00M
EBIT	-9.34M
Earnings Per Share (EPS)	-$8.58

Full Income Statement

Balance Sheet

The company has $5.50 million in cash and $827,957 in debt, giving a net cash position of $4.67 million or $2.32 per share.

Cash & Cash Equivalents	5.50M
Total Debt	827,957
Net Cash	4.67M
Net Cash Per Share	$2.32
Equity (Book Value)	5.12M
Book Value Per Share	2.55
Working Capital	4.05M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7.65M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Aethlon Medical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-396.93%
Shareholder Yield	n/a
Earnings Yield	-536.96%
FCF Yield	n/a

Analyst Forecast

The average price target for Aethlon Medical is $56.00, which is 4,416.13% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$56.00
Price Target Difference	4,416.13%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 9, 2025. It was a reverse split with a ratio of 0.125:1.

Last Split Date	Jun 9, 2025
Split Type	Reverse
Split Ratio	0.125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1